Full Text (PDF)
For 2010 (and beyond), this new page replaces our old “BPI Reports” news section. The editors were never happy with the time constraints of publishing news in a monthly magazine, so from now on you'll find a whole new take on the news in our Editors' Blog at the newly redesigned BPI website (www.bioprocessintl.com). We see something interesting almost every day, so we'd much rather try to make you aware of the latest developments while they're happening than wait three months to get them into print. And we hope you'll enjoy the more informal style online.
As for this page, we'll use it for a variety of notices related to the website, our editorial advisors, and the industry at large. As with antibody fragments — whether Fab or otherwise — we'll pull out the most useful part of a statistic, concept, development, or trend and offer it up here. We hope you enjoy this new look and our new approach!
In vaccine development and manufacturing, GE Healthcare provides a suite of scalable solutions from cell culture through purification to analysis, which offer flexibility and economy, improve purity and secure quality.
Register to download these two NEW application notes:
Microcarriers and disposable bioreactors for MDCK and Vero cell culture
Secure cell propagation with adherent cells at reduced cost and with increased flexibility
DNA removal from influenza virus culture
HTPD and DoE for development and optimization of a chromatography step for the removal of host cell derived genomic DNA
Practical Considerations for DoE Implementation in Quality By Design
Contractor Responsibilities in Outsourced Pharmaceutical Quality Control Testing
Measuring Manufacturing Cost and Its Impact on Organizations
Single-Use Technology
Fluorescence-Activated Cell Sorting for CGMP Processing of Therapeutic Cells
The Roles of Bioactivity Assays in Lot Release and Stability Testing